Skip to main content
. 2023 Sep 25;36:11951. doi: 10.3389/ti.2023.11951
Critical Path Institute’s Transplant Therapeutics Consortium
Government and Regulatory Agencies
 • National Institutes of Health
 • U.S. Food and Drug Administration
Academic Institutions
 • Charité – Universitätsmedizin Berlin
 • Helsinki University Hospital
 • Hospital do Rim
 • Houston Methodist Hospital
 • Katholieke Universiteit Leuven
 • Mayo Clinic
 • Necker Hospital, Paris Transplant Group
 • University of Colorado, Denver
 • University of Wisconsin, School of Medicine
 • University of Manitoba
Professional Societies
 • American Society of Transplantation
 • American Society of Transplant Surgeons
 • The European Society for Organ Transplantation
 • The Transplantation Society
Biopharmaceutical Industry and Diagnostic Companies
 • argenx
 • Bristol Myers Squibb
 • CareDx
 • CSL Behring
 • Eledon Pharmaceuticals
 • Eurofins Transplant Genomics
 • Hansa Biopharma
 • Immucor
 • Novartis
 • Sanofi
 • Takeda Pharmaceutical Company Limited
 • Talaris Therapeutics
 • Thermo Fisher Scientific Incorporated
 • Veloxis Pharmaceuticals
Additional Acknowledgments:
• Anat Tambur • Klaus Romero
• Byron Smith • Lauren Quinlan
• Cecile Olivier • Mark Haas
• Christina Higgins • Mike Pauley
• Christine Miller • Nicholas King
• Devrim Eren • Nicole Spear
• Erin Beach • Patrick Lang
• Grace Erhart • Rhoda Muse
• Hailey Davenport • Sarah David
• Howie Gebel • Stephen Karpen
• Jackson Burton • Stephen Piccoli
• John Holman • Zihan Cui
• Kitty Bogy